|
|
||||||||
IUPHAR Nomenclature Report |
Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D.); Laboratory of Genetics, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, United Kingdom (S.M.F.); Division of Neuroscience and Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom (A.J.H.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Centre National de la Recherche Scientifique, Montpellier, France (J.-P.P.); Institut de Recherches Internationales Servier (I.R.I.S.), Neuilly-sur-Seine, France (M.S.); and National Cardiovascular Center Research Institute, Suita, Osaka, Japan (M.K., K.K.)
Abstract
Abstract I. Introduction II. Growth Hormone Secretagogue Receptor 1a Designated as the Ghrelin Receptor III. Distribution of Receptor and mRNA Encoding the Receptor IV. Radiolabeled Ligands V. Agonists VI. Antagonists VII. Physiological Role VIII. Pathophysiological Role IX. Genetically Modified Animals A. Ghrelin Receptor B. Peptide
Ghrelin is a 28-amino acid peptide originally isolated from rat stomach and is cleaved from a 117-amino acid precursor. The sequence of the mature peptide from rats and mice differs by two amino acids from that of human ghrelin. Alternative splicing of the ghrelin gene transcript can result in the translation of a second biologically active peptide, des-Gln14-ghrelin. Both peptides have a unique post-translational modification, octanoylation of Ser3, which is essential for the binding to receptors in hypothalamus and pituitary and stimulating the release of growth hormone from the pituitary. The growth hormone secretagogue receptor (GHS-R1a, Swiss-Prot code Q92847, LocusLink ID 2693), a rhodopsin-like seven transmembrane spanning G protein-coupled receptors belonging to Family A, was cloned in 1996 from the pituitary and hypothalamus and shown to be the target of growth hormone secretagogues (GHS), a class of synthetic peptide and nonpeptide compounds causing growth hormone release from the anterior pituitary. In 1999, ghrelin was identified as the endogenous cognate ligand for this receptor. The purpose of this review is to propose an official International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR) nomenclature designating GHS-R1a as the ghrelin receptor to follow the convention of naming receptors after the endogenous agonist, abbreviated where necessary to GRLN.
This article has been cited by other articles:
![]() |
I. Johansson, S. Destefanis, N. D. Aberg, M. A. I. Aberg, K. Blomgren, C. Zhu, C. Ghe, R. Granata, E. Ghigo, G. Muccioli, et al. Proliferative and Protective Effects of Growth Hormone Secretagogues on Adult Rat Hippocampal Progenitor Cells Endocrinology, May 1, 2008; 149(5): 2191 - 2199. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Granata, F. Settanni, D. Gallo, L. Trovato, L. Biancone, V. Cantaluppi, R. Nano, M. Annunziata, P. Campiglia, E. Arnoletti, et al. Obestatin Promotes Survival of Pancreatic {beta}-Cells and Human Islets and Induces Expression of Genes Involved in the Regulation of {beta}-Cell Mass and Function Diabetes, April 1, 2008; 57(4): 967 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Holliday, B. Holst, E. A. Rodionova, T. W. Schwartz, and H. M. Cox Importance of Constitutive Activity and Arrestin-Independent Mechanisms for Intracellular Trafficking of the Ghrelin Receptor Mol. Endocrinol., December 1, 2007; 21(12): 3100 - 3112. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gauna, P. Uitterlinden, P. Kramer, R. M. Kiewiet, J. A. M. J. L. Janssen, P. J. D. Delhanty, M. O. van Aken, E. Ghigo, L. J. Hofland, A. P. N. Themmen, et al. Intravenous Glucose Administration in Fasting Rats Has Differential Effects on Acylated and Unacylated Ghrelin in the Portal and Systemic Circulation: A Comparison between Portal and Peripheral Concentrations in Anesthetized Rats Endocrinology, November 1, 2007; 148(11): 5278 - 5287. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gauna, R. M. Kiewiet, J. A. M. J. L. Janssen, B. van de Zande, P. J. D. Delhanty, E. Ghigo, L. J. Hofland, A. P. N. Themmen, and A. J. van der Lely Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E697 - E704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tropea, F. Tiberi, F. Minici, M. Orlando, M. F. Gangale, F. Romani, F. Miceli, S. Catino, S. Mancuso, M. Sanguinetti, et al. Ghrelin Affects the Release of Luteolytic and Luteotropic Factors in Human Luteal Cells J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3239 - 3245. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ribatti, M. T. Conconi, and G. G. Nussdorfer Nonclassic Endogenous Novel Regulators of Angiogenesis Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Granata, F. Settanni, L. Biancone, L. Trovato, R. Nano, F. Bertuzzi, S. Destefanis, M. Annunziata, M. Martinetti, F. Catapano, et al. Acylated and Unacylated Ghrelin Promote Proliferation and Inhibit Apoptosis of Pancreatic {beta}-Cells and Human Islets: Involvement of 3',5'-Cyclic Adenosine Monophosphate/Protein Kinase A, Extracellular Signal-Regulated Kinase 1/2, and Phosphatidyl Inositol 3-Kinase/Akt Signaling Endocrinology, February 1, 2007; 148(2): 512 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Naslund and J. G. Kral Impact of Gastric Bypass Surgery on Gut Hormones and Glucose Homeostasis in Type 2 Diabetes Diabetes, December 1, 2006; 55(Supplement_2): S92 - S97. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimizu, E. C. Chang, A. D. Shafton, D. M. Ferens, G. J. Sanger, J. Witherington, and J. B. Furness Evidence that stimulation of ghrelin receptors in the spinal cord initiates propulsive activity in the colon of the rat J. Physiol., October 1, 2006; 576(1): 329 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Levin, T. Edholm, P. T. Schmidt, P. Gryback, H. Jacobsson, M. Degerblad, C. Hoybye, J. J. Holst, J. F. Rehfeld, P. M. Hellstrom, et al. Ghrelin Stimulates Gastric Emptying and Hunger in Normal-Weight Humans J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3296 - 3302. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |